The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kazantseva I.A.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Kotov S.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Borodataja E.V.

GBUZ MO «Moskovskiĭ oblastnoĭ nauchno-issledovatelskiĭ klinicheskiĭ institut im. M.F. Vladimirskogo», Moskva

Sidorova O.P.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut

Borodin A.V.

Kafedra obshcheĭ khirurgii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Mitochondrial disorders in multiple sclerosis

Authors:

Kazantseva I.A., Kotov S.V., Borodataja E.V., Sidorova O.P., Borodin A.V.

More about the authors

Read: 1918 times


To cite this article:

Kazantseva IA, Kotov SV, Borodataja EV, Sidorova OP, Borodin AV. Mitochondrial disorders in multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8‑2):5‑9. (In Russ.)
https://doi.org/10.17116/jnevro20181180825

Recommended articles:
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107

References:

  1. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet. 2008;83(2):254-260. https://doi.org/10.1016/j.ajhg.2008.07.004
  2. Tanaka M, Nishigaki Y, Fuku N, Ibi T, Sahashi K, Koga Y. Therapeutic potential of pyruvate therapy for mitochondrial diseases. Mitochondrion. 2007;7(6):399-401. https://doi.org/10.1016/j.mito
  3. Kotov SV, Sidorova OP, Kunitsyna AN, Turbina LG, Borodataya EV, Smirnov VB, Kotov AS. Age-related changes of mitochondria. Clinical gerontology. 2010;16(9-10):41. (In Russ.) https://doi.org/10.1155/2015/178564
  4. Borodataya EV, Kotov SV, Sidorova OP, Polyakov AV, Kotov AS. Mitochondrial failure and its correction by noben (idebenone) in chorea Huntington. All-Russian scientific-practical conference Vascular diseases of the nervous system. Materials. SPb. 2011. (In Russ.)
  5. Kotov SV, Agafonov BV, Kazantseva IA, Sidorova OP, Borodataya EV. Mitochondrial disorders in hereditary neuromuscular disorders and myasthenia gravis. Russian scientific-practical conference with international participation «Differential diagnostics in the clinic of neuromuscular diseases». M., March 28—29, 2014. (In Russ.)
  6. Andrews HE, Nichols PP, Bates D, Turnbull DM. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis. Med Hypotheses. 2005;64(4):669-677. https://doi.org/10.1016/j.mehy.2009.06.024
  7. Witte ME, Bø L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, van der Valk P, van Horssen J. Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol. 2009;219(2):193-204. https://doi.org/10.1002/path.2582
  8. Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, van Horssen J, Lassmann H. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain. 2012;135(3):886-899. https://doi.org/10.1093/brain/aww205
  9. Rice CM, Sun M, Kemp K, Gray E, Wilkins A, Scolding NJ. Mitochondrial sirtuins — a new therapeutic target for repair and protection in multiple sclerosis. Eur J Neurosci. 2012;35(12):1887-1893. https://doi.org/10.1111/ejn.13524
  10. Campbell GR, Kraytsberg Y, Krishnan KJ, Ohno N, Ziabreva I, Reeve A, Trapp BD, Newcombe J, Reynolds R, Lassmann H, Khrapko K, Turnbull DM, Mahad DJ. Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis. Acta Neuropathol. 2012;124(2):209-220.
  11. Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, Lassmann H, Turnbull DM. Mitochondrial changes within axons in multiple sclerosis. Brain. 2009;132(5):1161-1174. https://doi.org/10.1007/s00401-010-0710-1
  12. Zambonin JL, Zhao C, Ohno N, Campbell GR, Engeham S, Ziabreva I, Schwarz N, Lee SE, Frischer JM, Turnbull DM, Trapp BD, Lassmann H, Franklin RJ, Mahad DJ. Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis. Brain. 2011;134(7):1901-1913. https://doi.org/10.1093/brain/aww205
  13. van Horssen J, Witte ME, Ciccarelli O. The role of mitochondria in axonal degeneration and tissue repair in MS. Mult Scler. 2012;18(8):1058-1067. https://doi.org/10.3390/ijms161023463
  14. Safavizadeh N, Rahmani SA, Zaefizadeh M. Investigation of cytochrome c oxidase gene subunits expression on the Multiple sclerosis. Indian J Hum Genet. 2013;19(1):18-25. https://doi.org/10.4103/0971-6866.112879
  15. Iñarrea P, Alarcia R, Alava MA, Capablo JL, Casanova A, Iñiguez C, Iturralde M, Larrodé P, Martín J, Mostacero E, Ara JR. Mitochondrial complex enzyme activities and cytochrome C expression changes in multiple sclerosis. Mol Neurobiol. 2014;49(1):1-9. https://doi.org/10.1093/cercor/bhs139
  16. Mao P, Manczak M, Shirendeb UP, Reddy PH. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Biochim Biophys Acta. 2013;1832(12):2322-2231. https://doi.org/10.1016/j.bbadis.2009.07.002
  17. Witte ME, Mahad DJ, Lassmann H, van Horssen J. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol Med. 2014;20(3):179-187. https://doi.org/10.1016/j.molmed
  18. Talla V, Porciatti V, Chiodo V, Boye SL, Hauswirth WW, Guy J. Gene therapy with mitochondrial heat shock protein 70 suppresses visual loss and optic atrophy in experimental autoimmune encephalomyelitis. Invest Ophthalmol Vis Sci. 2014;55(8):5214-5226. https://doi.org/10.1167/iovs.16-19309
  19. Tranah GJ, Santaniello A, Caillier SJ, D’Alfonso S, Martinelli Boneschi F, Hauser SL, Oksenberg JR. Mitochondrial DNA sequence variation in multiple sclerosis. Neurology. 2015;85(4):325-330. https://doi.org/10.1007/s00415-015-7893-2
  20. Singhal NK, Li S, Arning E, Alkhayer K, Clements R, Sarcyk Z, Dassanayake RS, Brasch NE, Freeman E, Bottiglieri T, McDonough J. Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis. J Neurosci. 2015;35(45):5170-5186. https://doi.org/10.21767/2171-6625.1000142
  21. Haider L. Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis. Oxid Med Cell Longev. 2015;725370. https://doi.org/10.1155/2016/9460462
  22. De Nuccio C, Bernardo A, Cruciani C, De Simone R, Visentin S, Minghetti L. Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation. Exp Neurol. 2015;271:506-514. https://doi.org/10.1097/NEN.0b013e3181a9d503

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.